{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T14:32:20Z","timestamp":1787927540167,"version":"build-2784847793"},"reference-count":43,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100012533","name":"Minia University","doi-asserted-by":"publisher","award":["MPEC 240302"],"award-info":[{"award-number":["MPEC 240302"]}],"id":[{"id":"10.13039\/501100012533","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012533","name":"Minia University","doi-asserted-by":"publisher","award":["NCT06728982"],"award-info":[{"award-number":["NCT06728982"]}],"id":[{"id":"10.13039\/501100012533","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jpet.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.jpet.2026.104970","type":"journal-article","created":{"date-parts":[[2026,6,19]],"date-time":"2026-06-19T16:18:04Z","timestamp":1781885884000},"page":"104970","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Metformin enhances the pathological response in nondiabetic patients with rectal cancer undergoing neoadjuvant chemoradiotherapy: A randomized controlled trial"],"prefix":"10.1016","volume":"393","author":[{"ORCID":"https:\/\/orcid.org\/0009-0003-3137-1824","authenticated-orcid":false,"given":"Omar Mohamed","family":"Awad","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mona Ali","family":"Saber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-7457-4425","authenticated-orcid":false,"given":"Nada Hussein","family":"Ali Sholkamy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmad Mostafa","family":"Abdel-Azeez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5447-6034","authenticated-orcid":false,"given":"Eman Mohamed","family":"Sadek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2865-145X","authenticated-orcid":false,"given":"Fatma Mohamed","family":"Mady","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.jpet.2026.104970_bib1","first-page":"10","article-title":"Cancer statistics, 2025","volume":"75","author":"Siegel","year":"2025","journal-title":"CA Cancer J Clin"},{"issue":"3","key":"10.1016\/j.jpet.2026.104970_bib2","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1016\/j.radonc.2014.04.013","article-title":"Anal cancer: ESMO-ESSO-ESTRO clinical practice guidelines for diagnosis, treatment and follow-up","volume":"111","author":"Glynne-Jones","year":"2014","journal-title":"Radiother Oncol"},{"issue":"9","key":"10.1016\/j.jpet.2026.104970_bib3","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1016\/j.annonc.2025.05.528","article-title":"Localised rectal cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up","volume":"36","author":"Hofheinz","year":"2025","journal-title":"Ann Oncol"},{"issue":"9","key":"10.1016\/j.jpet.2026.104970_bib4","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1016\/S1470-2045(10)70172-8","article-title":"Long-term outcome in patients with a pathological complete response after chemoradiation for rectal cancer: a pooled analysis of individual patient data","volume":"11","author":"Maas","year":"2010","journal-title":"Lancet Oncol"},{"issue":"1","key":"10.1016\/j.jpet.2026.104970_bib5","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/s13014-021-01746-0","article-title":"The watch-and-wait strategy versus surgical resection for rectal cancer patients with a clinical complete response after neoadjuvant chemoradiotherapy","volume":"16","author":"Wang","year":"2021","journal-title":"Radiat Oncol"},{"issue":"2","key":"10.1016\/j.jpet.2026.104970_bib6","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/S1470-2045(15)00467-2","article-title":"Watch-and-wait approach versus surgical resection after chemoradiotherapy for patients with rectal cancer (the OnCoRe project): a propensity-score matched cohort analysis","volume":"17","author":"Renehan","year":"2016","journal-title":"Lancet Oncol"},{"issue":"5","key":"10.1016\/j.jpet.2026.104970_bib7","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1097\/SLA.0b013e31824f1c21","article-title":"Low anterior resection syndrome score: development and validation of a symptom-based scoring system for bowel dysfunction after low anterior resection for rectal cancer","volume":"255","author":"Emmertsen","year":"2012","journal-title":"Ann Surg"},{"issue":"9","key":"10.1016\/j.jpet.2026.104970_bib8","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1111\/codi.12244","article-title":"Bowel dysfunction after low anterior resection with and without neoadjuvant therapy for rectal cancer: a population-based cross-sectional study","volume":"15","author":"Bregendahl","year":"2013","journal-title":"Colorectal Dis"},{"key":"10.1016\/j.jpet.2026.104970_bib9","doi-asserted-by":"crossref","DOI":"10.1177\/17588359251332466","article-title":"Total neoadjuvant therapy in high-risk rectal cancer: organ preservation and survival outcomes in a single-center retrospective cohort","volume":"17","author":"Zhang","year":"2025","journal-title":"Ther Adv Med Oncol"},{"issue":"9","key":"10.1016\/j.jpet.2026.104970_bib10","doi-asserted-by":"crossref","first-page":"e1555","DOI":"10.1002\/onco.13824","article-title":"Total neoadjuvant therapy (TNT) versus standard neoadjuvant chemoradiotherapy for locally advanced rectal cancer: a systematic review and meta-analysis","volume":"26","author":"Liu","year":"2021","journal-title":"Oncologist"},{"issue":"1","key":"10.1016\/j.jpet.2026.104970_bib11","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/S1470-2045(20)30555-6","article-title":"Short-course radiotherapy followed by chemotherapy before total mesorectal excision (TME) versus preoperative chemoradiotherapy, TME, and optional adjuvant chemotherapy in locally advanced rectal cancer (RAPIDO): a randomised, open-label, phase 3 trial","volume":"22","author":"Bahadoer","year":"2021","journal-title":"Lancet Oncol"},{"issue":"5","key":"10.1016\/j.jpet.2026.104970_bib12","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1016\/S1470-2045(21)00079-6","article-title":"Neoadjuvant chemotherapy with FOLFIRINOX and preoperative chemoradiotherapy for patients with locally advanced rectal cancer (UNICANCER-PRODIGE 23): a multicentre, randomised, open-label, phase 3 trial","volume":"22","author":"Conroy","year":"2021","journal-title":"Lancet Oncol"},{"issue":"1","key":"10.1016\/j.jpet.2026.104970_bib13","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1186\/s12876-025-03709-1","article-title":"Predictors of pathological complete response after total neoadjuvant treatment using short course radiotherapy for locally advanced rectal cancer","volume":"25","author":"Yacoub","year":"2025","journal-title":"BMC Gastroenterol"},{"issue":"7","key":"10.1016\/j.jpet.2026.104970_bib14","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1016\/S1470-2045(07)70202-4","article-title":"Non-operative treatment after neoadjuvant chemoradiotherapy for rectal cancer","volume":"8","author":"O\u2019Neill","year":"2007","journal-title":"Lancet Oncol"},{"issue":"7","key":"10.1016\/j.jpet.2026.104970_bib15","doi-asserted-by":"crossref","first-page":"909","DOI":"10.6004\/jnccn.2018.7032","article-title":"Evolving treatment paradigm in the treatment of locally advanced rectal cancer","volume":"16","author":"Smith","year":"2018","journal-title":"J Natl Compr Canc Netw"},{"issue":"6","key":"10.1016\/j.jpet.2026.104970_bib16","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.3390\/medicina61061021","article-title":"Metformin: a dual-role player in cancer treatment and prevention: a comprehensive systematic review and meta-analysis","volume":"61","author":"Rangraze","year":"2025","journal-title":"Medicina (Kaunas)"},{"issue":"3","key":"10.1016\/j.jpet.2026.104970_bib17","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1038\/nrc3215","article-title":"The insulin and insulin-like growth factor receptor family in neoplasia: an update","volume":"12","author":"Pollak","year":"2012","journal-title":"Nat Rev Cancer"},{"issue":"10","key":"10.1016\/j.jpet.2026.104970_bib18","doi-asserted-by":"crossref","first-page":"2323","DOI":"10.2337\/dc11-0512","article-title":"Reduced risk of colorectal cancer with metformin therapy in patients with type 2 diabetes: a meta-analysis","volume":"34","author":"Zhang","year":"2011","journal-title":"Diabetes Care"},{"issue":"1","key":"10.1016\/j.jpet.2026.104970_bib19","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1186\/s13046-019-1495-2","article-title":"Metformin in colorectal cancer: molecular mechanism, preclinical and clinical aspects","volume":"38","author":"Kamarudin","year":"2019","journal-title":"J Exp Clin Cancer Res"},{"issue":"6","key":"10.1016\/j.jpet.2026.104970_bib20","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1016\/j.cmet.2014.09.018","article-title":"Metformin: from mechanisms of action to therapies","volume":"20","author":"Foretz","year":"2014","journal-title":"Cell Metab"},{"issue":"9","key":"10.1016\/j.jpet.2026.104970_bib21","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1158\/1940-6207.CAPR-10-0186","article-title":"Metformin suppresses colorectal aberrant crypt foci in a short-term clinical trial","volume":"3","author":"Hosono","year":"2010","journal-title":"Cancer Prev Res (Phila)"},{"issue":"24","key":"10.1016\/j.jpet.2026.104970_bib22","doi-asserted-by":"crossref","first-page":"6741","DOI":"10.1158\/1078-0432.CCR-13-1787","article-title":"Reprogramming metabolism with metformin improves tumor oxygenation and radiotherapy response","volume":"19","author":"Zannella","year":"2013","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.jpet.2026.104970_bib23","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2023.1216911","article-title":"Metformin is a metabolic modulator and radiosensitiser in rectal cancer","volume":"13","author":"Buckley","year":"2023","journal-title":"Front Oncol"},{"issue":"7","key":"10.1016\/j.jpet.2026.104970_bib24","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1097\/DCR.0000000000001626","article-title":"Metformin as an alternative radiosensitizing agent to 5-fluorouracil during neoadjuvant treatment for rectal cancer","volume":"63","author":"Fernandes","year":"2020","journal-title":"Dis Colon Rectum"},{"issue":"1","key":"10.1016\/j.jpet.2026.104970_bib25","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.radmp.2020.12.002","article-title":"Impact of metformin on the therapeutic effect of radiotherapy","volume":"2","author":"Agbele","year":"2021","journal-title":"Radiat Med Prot"},{"issue":"1","key":"10.1016\/j.jpet.2026.104970_bib26","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1186\/s12957-023-03087-6","article-title":"Metformin increases pathological responses to rectal cancers with neoadjuvant chemoradiotherapy: a systematic review and meta-analysis","volume":"21","author":"Lai","year":"2023","journal-title":"World J Surg Oncol"},{"key":"10.1016\/j.jpet.2026.104970_bib27","first-page":"60","article-title":"Metformin with neoadjuvant chemoradiation to improve pathologic response in rectal cancer: a pilot phase I\/II trial","volume":"30","author":"Wong","year":"2021","journal-title":"Clin Transl Radiat Oncol"},{"issue":"3","key":"10.1016\/j.jpet.2026.104970_bib28","doi-asserted-by":"crossref","first-page":"396","DOI":"10.3390\/ph17030396","article-title":"Metformin and breast cancer: current findings and future perspectives from preclinical and clinical studies","volume":"17","author":"Corleto","year":"2024","journal-title":"Pharmaceuticals (Basel)"},{"issue":"1","key":"10.1016\/j.jpet.2026.104970_bib29","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1186\/s13058-019-1204-2","article-title":"Metformin overcomes resistance to cisplatin in triple-negative breast cancer (TNBC) cells by targeting RAD51","volume":"21","author":"Lee","year":"2019","journal-title":"Breast Cancer Res"},{"issue":"5","key":"10.1016\/j.jpet.2026.104970_bib30","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.3109\/0284186X.2012.718096","article-title":"Metformin use and improved response to therapy in esophageal adenocarcinoma","volume":"52","author":"Skinner","year":"2013","journal-title":"Acta Oncol"},{"issue":"1","key":"10.1016\/j.jpet.2026.104970_bib31","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1002\/cam4.54","article-title":"Metformin use and improved response to therapy in rectal cancer","volume":"2","author":"Skinner","year":"2013","journal-title":"Cancer Med"},{"issue":"6","key":"10.1016\/j.jpet.2026.104970_bib32","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1007\/s00432-016-2148-x","article-title":"Metformin enhances the response to radiotherapy in diabetic patients with rectal cancer","volume":"142","author":"Oh","year":"2016","journal-title":"J Cancer Res Clin Oncol"},{"issue":"3","key":"10.1016\/j.jpet.2026.104970_bib33","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.canep.2012.12.009","article-title":"Association of metformin use with cancer incidence and mortality: a meta-analysis","volume":"37","author":"Zhang","year":"2013","journal-title":"Cancer Epidemiol"},{"issue":"2","key":"10.1016\/j.jpet.2026.104970_bib34","first-page":"3677","article-title":"Role of metformin in enhancing response to neoadjuvant chemo-radiotherapy in patients with locally advanced rectal carcinoma","volume":"25","author":"Abo Shama","year":"2021","journal-title":"Ann Rom Soc Cell Biol"},{"key":"10.1016\/j.jpet.2026.104970_bib35","doi-asserted-by":"crossref","DOI":"10.1200\/JCO.2018.36.15_suppl.e15642","article-title":"Impact of metformin use on pathologic response following chemoradiotherapy in rectal cancer","volume":"36","author":"Thomas","year":"2018","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jpet.2026.104970_bib36","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1016\/j.jss.2021.06.079","article-title":"Is metformin associated with improved response to neoadjuvant chemoradiotherapy in locally advanced rectal cancer?","volume":"268","author":"Planellas","year":"2021","journal-title":"J Surg Res"},{"issue":"8","key":"10.1016\/j.jpet.2026.104970_bib37","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0106277","article-title":"Diet-Induced obesity modulates epigenetic responses to ionizing radiation in mice","volume":"9","author":"Vares","year":"2014","journal-title":"PLoS One"},{"issue":"12","key":"10.1016\/j.jpet.2026.104970_bib38","doi-asserted-by":"crossref","first-page":"2993","DOI":"10.1158\/1078-0432.CCR-15-1839","article-title":"PlGF\/VEGFR-1 signaling promotes macrophage polarization and accelerated tumor progression in obesity","volume":"22","author":"Incio","year":"2016","journal-title":"Clin Cancer Res"},{"issue":"3","key":"10.1016\/j.jpet.2026.104970_bib39","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1097\/COC.0000000000000150","article-title":"Oncologic and functional hazards of obesity among patients with locally advanced rectal cancer following neoadjuvant chemoradiation therapy","volume":"40","author":"Park","year":"2017","journal-title":"Am J Clin Oncol"},{"key":"10.1016\/j.jpet.2026.104970_bib40","doi-asserted-by":"crossref","first-page":"475","DOI":"10.2147\/CMAR.S385278","article-title":"Metformin induces a caspase 3-unrelated apoptosis in human colorectal cancer cell lines HCT116 and SW620","volume":"15","author":"Rosidi","year":"2023","journal-title":"Cancer Manag Res"},{"issue":"9","key":"10.1016\/j.jpet.2026.104970_bib41","doi-asserted-by":"crossref","first-page":"1384","DOI":"10.1038\/s41591-018-0125-4","article-title":"Metformin inhibits gluconeogenesis via a redox-dependent mechanism in vivo","volume":"24","author":"Madiraju","year":"2018","journal-title":"Nat Med"},{"issue":"2","key":"10.1016\/j.jpet.2026.104970_bib42","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1016\/j.ijrobp.2015.06.003","article-title":"Metformin: a novel biological modifier of tumor response to radiation therapy","volume":"93","author":"Koritzinsky","year":"2015","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"3","key":"10.1016\/j.jpet.2026.104970_bib43","doi-asserted-by":"crossref","first-page":"993","DOI":"10.7150\/thno.104872","article-title":"Metformin-based nanomedicines for reprogramming tumor immune microenvironment","volume":"15","author":"Liu","year":"2025","journal-title":"Theranostics"}],"container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022356526011699?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022356526011699?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T14:11:15Z","timestamp":1787926275000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022356526011699"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":43,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2026,8]]}},"alternative-id":["S0022356526011699"],"URL":"https:\/\/doi.org\/10.1016\/j.jpet.2026.104970","relation":{},"ISSN":["0022-3565"],"issn-type":[{"value":"0022-3565","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Metformin enhances the pathological response in nondiabetic patients with rectal cancer undergoing neoadjuvant chemoradiotherapy: A randomized controlled trial","name":"articletitle","label":"Article Title"},{"value":"The Journal of Pharmacology and Experimental Therapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jpet.2026.104970","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 American Society for Pharmacology and Experimental Therapeutics. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"104970"}}